Diagnostics

Why is important to pay attention to cognition in multiple sclerosis? 3:20
Why is important to pay attention to cognition in multiple sclerosis?
Claire Riley • 26 Feb 2021
Autoimmune encephalitis: understanding prevalence and pathogenesis 2:16
Autoimmune encephalitis: understanding prevalence and pathogenesis
Divyanshu Dubey • 15 Feb 2021
Diagnostic biomarkers and efficacious treatments are unmet needs in autoimmune encephalitis 1:45
Diagnostic biomarkers and efficacious treatments are unmet needs in autoimmune encephalitis
Divyanshu Dubey • 15 Feb 2021
Paraneoplastic etiology of myeloneuropathy 1:47
Paraneoplastic etiology of myeloneuropathy
Divyanshu Dubey • 15 Jan 2021
Revising the neuromyelitis optica criteria 4:39
Revising the neuromyelitis optica criteria
Angela Vincent • 30 Oct 2020
Comorbidities in multiple sclerosis patients 3:33
Comorbidities in multiple sclerosis patients
Melinda Magyari • 2 Nov 2020
The drawbacks of telemedicine 1:57
The drawbacks of telemedicine
Jessica Ailani • 26 Oct 2020
Are biomarkers for Alzheimer’s disease ready for clinical practice? 2:25
Are biomarkers for Alzheimer’s disease ready for clinical practice?
Giancarlo Logroscino • 22 Oct 2020
Neuromyelitis optica: new treatments and areas of development 7:45
Neuromyelitis optica: new treatments and areas of development
Brian Weinshenker • 26 Oct 2020
MS diagnosis: are the 2017 MS McDonald criteria too liberal? 6:41
MS diagnosis: are the 2017 MS McDonald criteria too liberal?
Brian Weinshenker • 26 Oct 2020
The problem with defining types of MS 3:10
The problem with defining types of MS
Gavin Giovannoni • 19 Oct 2020
The role of kynurenines in the pathogenesis of MS 3:25
The role of kynurenines in the pathogenesis of MS
Laszlo Vecsei • 28 Oct 2020
The advantages of monitoring epilepsy with ambulatory EEGs 1:24
The advantages of monitoring epilepsy with ambulatory EEGs
Antonio Gil-Nagel • 27 Oct 2020
The future of ambulatory EEGs to monitor epilepsy 2:05
The future of ambulatory EEGs to monitor epilepsy
Martin Brodie • 23 Oct 2020
The future to telemedicine in developed and developing countries 2:15
The future to telemedicine in developed and developing countries
Martin Brodie • 23 Oct 2020
Defining Alzheimer’s disease: clinical or biological 2:22
Defining Alzheimer’s disease: clinical or biological
Bart De Strooper • 19 Oct 2020
The content of VJNeurology is intended for healthcare professionals